| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016426 |
| Receipt No. | R000019077 |
| Official scientific title of the study | Dose high dose remifentanil induce postoperative hyperalgesia? |
| Date of disclosure of the study information | 2015/03/01 |
| Last modified on | 2019/01/17 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Dose high dose remifentanil induce postoperative hyperalgesia? | |
| Title of the study (Brief title) | remifentanil induced hyperalgesia | |
| Region |
|
|
| Condition | |||
| Condition | postoperative pain | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To examine effects of continuous ketamine administration on postoperative hyperalgesia induced by high dose remifentanil. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Visual analogue pain scale
Amount of supplemental anesthetics Side effects of anesthetics |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | sham | |
| Interventions/Control_2 | ketamine administration | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | oral surgery
physical status 1 and 2 |
|||
| Key exclusion criteria | intracranial hypertension
taking pain killer mental disease alcoholism |
|||
| Target sample size | 52 | |||
| Research contact person | |
| Name of lead principal investigator | Kanta Kido |
| Organization | Tohoku Univ. Hosp. |
| Division name | Dept. of dental anesthesia and pain management, |
| Address | 4-1Seiryo-machi, Aoba-ku, Sendai, Japan |
| TEL | 022-717-8420 |
| kido@m.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Kanta Kido |
| Organization | Tohoku Univ. Hosp. |
| Division name | Dept. of dental anesthesia and pain management, |
| Address | 4-1Seiryo-machi, Aoba-ku, Sendai, Japan |
| TEL | 022-717-8420 |
| Homepage URL | |
| kido@m.tohoku.ac.jp | |
| Sponsor | |
| Institute | Dept. of dental anesthesia and pain management, Tohoku Univ. Hosp. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東北大学病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | Remifentanil is associated with acute opioid tolerance that can lead to increased postoperative consumption of opioid analgesics. The purpose of this study was to determine whether a low dose of ketamine prevents remifentanil-induced acute opioid tolerance and affects the neutrophil-lymphocyte ratio (NLR), a newly recognized biomarker of in ambition.
High-dose intraoperative remifentanil induced postoperative acute opioid tolerance that was prevented by infusion of low-dose ketamine. Ketamine increased the postoperative NLR associated with decreased fentanyl requirement for postoperative pain control. |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019077 |